Aurobindo Pharma Fundamental Analysis
AUROPHARMA
1571.739.20 (-2.43%)
Last updated on 23 Oct, 2026 | 15:51 IST
Free Demat with Zero AMC*
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Aurobindo Pharma Fundamentals
P/E Ratio
24.32
P/B Ratio
2.32
Div. Yield
0.25
Sector P/E
37.75
Sector P/B
3.16
Sec. Div. Yield
0.54
Aurobindo Pharma Fundamentals is currently trading with a P/E Ratio of 24.32, compared to the sector average of 37.75. Its P/B Ratio stands at 2.32, while the sector’s is 3.16. In terms of returns, the stock offers a Dividend Yield of 0.25%, which is than the sector’s 0.54%.
Aurobindo Pharma Score Card
Price
Expensive
Growth
Poor
Quality
Good
Management
Good
On its scorecard, Aurobindo Pharma reflects: Price – Expensive, Growth – Poor, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.
Aurobindo Pharma Associated Pages
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in AUROPHARMA
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Or Download Choice FinX App
Invest in AUROPHARMA
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade